Changing Complication Profiles in the Era of Robotic Ivor Lewis Esophagectomy: A Comparative Analysis of Open, Hybrid, and Fully Robotic Techniques

<b>Background:</b> Novel robotic surgical techniques have substantially improved the safety and outcomes of Ivor Lewis esophagectomy, offering greater precision, reduced surgical trauma, and more radical lymphadenectomy compared to conventional approaches. While perioperative results are increasingly promising, the adoption of robotic technology appears to be accompanied by an emerging set of procedure-specific complications not previously encountered-or encountered with different frequency-in open surgery. Understanding this evolving complication profile is essential to fully realize the oncological potential of robotic esophagectomy. <b>Methods:</b> This retrospective single-center study compared 407 consecutive patients undergoing Ivor Lewis esophagectomy at a high-volume center (OPE <i>n</i> = 163; HRB <i>n</i> = 75; FRB <i>n</i> = 169; 2012-2023) regarding three pathophysiologically motivated primary endpoints within 12 months: paraconduit herniation, chylothorax, and neo-esophagus-airway fistula. <b>Results:</b> One-year survival was 71.8%, 74.7%, and 82.2% (<i>p</i> = 0.073). Chylothorax was significantly more frequent in FRB (12.4%) than in OPE (2.5%) or HRB (2.7%) (<i>p</i> < 0.001), with surgical approach as sole independent predictor. Lymphangiography in three FRB patients demonstrated thoracic duct integrity in all; leakage originated from the celiac lymphadenectomy field ascending transhiatally-suggesting a distinct mechanism potentially linked to surgical radicality. All cases resolved conservatively. Neo-esophagus-airway fistula occured significantly less frequently with robotic approaches (FRB 0.6% vs. OPE 4.9%; <i>p</i> = 0.031). Paraconduit herniation did not differ significantly within 12 months (<i>p</i> = 0.272). <b>Conclusions:</b> The complication profile of robotic Ivor Lewis esophagectomy reflects its oncological ambition: elevated chylothorax rates may correlate with radical lymphadenectomy and represent an acceptable trade-off within a multimodal treatment strategy. Fistula risk is meaningfully reduced. These findings support robotic esophagectomy as a safe and effective approach in experienced centers.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-03-15
DOI
https://doi.org/10.3390/cancers18060954
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Changing Complication Profiles in the Era of Robotic Ivor Lewis Esophagectomy: A Comparative Analysis of Open, Hybrid, and Fully Robotic Techniques

A Pascher, Sebastian Weberskirch, Mazen A. Juratli, Jennifer Merten et al.
Cancers
Esophageal Cancer Research and Treatment
article

Changing Complication Profiles in the Era of Robotic Ivor Lewis Esophagectomy: A Comparative Analysis of Open, Hybrid, and Fully Robotic Techniques

A Pascher, Sebastian Weberskirch, Mazen A. Juratli, Jennifer Merten, Ann-Kathrin Eichelmann, Jens Peter Hoelzen, Nader El-Sourani, Neele Wilkens
article en

Abstract

<b>Background:</b> Novel robotic surgical techniques have substantially improved the safety and outcomes of Ivor Lewis esophagectomy, offering greater precision, reduced surgical trauma, and more radical lymphadenectomy compared to conventional approaches. While perioperative results are increasingly promising, the adoption of robotic technology appears to be accompanied by an emerging set of procedure-specific complications not previously encountered-or encountered with different frequency-in open surgery. Understanding this evolving complication profile is essential to fully realize the oncological potential of robotic esophagectomy. <b>Methods:</b> This retrospective single-center study compared 407 consecutive patients undergoing Ivor Lewis esophagectomy at a high-volume center (OPE <i>n</i> = 163; HRB <i>n</i> = 75; FRB <i>n</i> = 169; 2012-2023) regarding three pathophysiologically motivated primary endpoints within 12 months: paraconduit herniation, chylothorax, and neo-esophagus-airway fistula. <b>Results:</b> One-year survival was 71.8%, 74.7%, and 82.2% (<i>p</i> = 0.073). Chylothorax was significantly more frequent in FRB (12.4%) than in OPE (2.5%) or HRB (2.7%) (<i>p</i> < 0.001), with surgical approach as sole independent predictor. Lymphangiography in three FRB patients demonstrated thoracic duct integrity in all; leakage originated from the celiac lymphadenectomy field ascending transhiatally-suggesting a distinct mechanism potentially linked to surgical radicality. All cases resolved conservatively. Neo-esophagus-airway fistula occured significantly less frequently with robotic approaches (FRB 0.6% vs. OPE 4.9%; <i>p</i> = 0.031). Paraconduit herniation did not differ significantly within 12 months (<i>p</i> = 0.272). <b>Conclusions:</b> The complication profile of robotic Ivor Lewis esophagectomy reflects its oncological ambition: elevated chylothorax rates may correlate with radical lymphadenectomy and represent an acceptable trade-off within a multimodal treatment strategy. Fistula risk is meaningfully reduced. These findings support robotic esophagectomy as a safe and effective approach in experienced centers.

CancersVol. 18(6)
University Hospital Münster (DE)
Good health and well-being
Openalex Percentile: Top 21%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.